Omega Diagnostics Share Discussion Threads

[barrywhit] 17/3/2017 12:19

It has kept the momentum going, leading into a Trading Update and Notice of Results due in April, not too long to wait expecting/hoping for a Bullish Update....

[rivaldo] 17/3/2017 12:07

Looking strong - and good to see buying at the full 21.5p offer.

[barrywhit] 09/3/2017 11:36

So it shows the bid @ 20.25 but you can sell at 21p....(dummy sell)

[longshanks] 09/3/2017 11:10

I don't believe the MMs are "struggling" with it: they are just looking to use a waiting game to flush out any short-term and CFD holders on their T3, T5, T20 accounts. Whilst stock is limited at 21.5p, the gate is not shut: I am sure that if I offered 22p for stock, I would get as much as I wanted.

[longshanks] 09/3/2017 10:38

It says a lot when you can't even buy 250 shares without a negotiated trade

[dibs61] 09/3/2017 10:03

I too dislike overpaying but I suspect your purchase this morning will look rather cheap at some point.

The stock is strongly bid once again this morning. MM's are struggling with this at the moment. They clearly need sellers so sooner or later they'll have to take the price up

[longshanks] 09/3/2017 09:38

I hate "over-paying" for stock so my fill price targets are always aggressive. Some stock is available but not much - I managed to get another 15k at 21.09 this morning.

[longshanks] 09/3/2017 00:07

I was partially filled with 10k, will look to fill the rest tomorrow

[dibs61] 08/3/2017 19:07

Did you set a price limit longshanks?

Btw I see I was correct with the order filling prediction viz a viz the 70k delayed trade @ 21.5

No doubt that was our Richard back in the market again

[longshanks] 08/3/2017 16:04

I opened an order this morning that has yet to be filled

[dibs61] 08/3/2017 15:31

Anyone else chuckling at the tree shake. Dropped the bid by a ridiculous amount on miniscule volume.

Someone has an order to fill ;)

[hyperboreus] 07/3/2017 16:13

Ha ha not that competitively priced then Dibs61, I think you will find that the price will be circa $5 per test however given the slump in sterling since Brexit it ain't that far off now :-)

[barrywhit] 07/3/2017 15:59

Richard Sneller is now the largest holder takes over from L & G who have 12.88%

[dibs61] 07/3/2017 09:30

If (or perhaps when) CD4 comes online I see the share price a lot higher than 50p. A modest take of the market would see revenues catapulted from where they are now. And the kits are competitively priced @ £5 a pop

[longshanks] 07/3/2017 08:56

Not sure he is in a hurry - but he clearly has some funds available to invest and he still clearly sees ODX as cheap.When you consider that many of the executive options only vest when the share price has risen above 50p, there is still lots of potential here.

[rivaldo] 07/3/2017 08:51

...and Richard Sneller is a man in a hurry - he's bought another 350,000 shares since his last RNS and now has 13.05m, going above 12% per today's RNS:

[barrywhit] 07/3/2017 08:50

Richard Sneller still keen even at this level.....bodes well...

[rivaldo] 07/3/2017 08:48

Looking good here - and a nice buy just now at 22.55p, well above the offer price.

[dibs61] 06/3/2017 10:15

Rerating? CD4 news? IDS development? Whatever it is it's good and we've also got a clear chart breakout after a long period of consolidation

[longshanks] 06/3/2017 09:37

Don't forget there is a story in the fundamentals too (the third reason).I am very pleased to see this moving towards fair value.

[p1nkfish] 06/3/2017 09:34

At last, potential will out.

[barrywhit] 06/3/2017 08:38

Both reasons i would say rivaldo...

[rivaldo] 06/3/2017 08:08

Nice start - no trades yet AFAICS? Must be decent underlying demand as per the above posts (and/or a lack of available stock).

[barrywhit] 03/3/2017 13:12

Well you are right longshanks the stock does remain well bid, here's hoping it continues......GLA LTH's

[longshanks] 02/3/2017 22:26

Stock remains well bid so I can see the trading range being taken higher in the near term.I have taken a look back at the RNS' issued three years ago when visitect CD4 was a clear focus.The company's enthusiasm has been much more circumspect whilst eradicating the ATE. Now that commercialisation is within sight once more I would expect the bullish tones of 2014 to re-emerge.The EOY trading update should make good reading.